These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
215 related articles for article (PubMed ID: 35292828)
1. Targeting PD-L1 and TIGIT could restore intratumoral CD8 T cell function in human colorectal cancer. Thibaudin M; Limagne E; Hampe L; Ballot E; Truntzer C; Ghiringhelli F Cancer Immunol Immunother; 2022 Oct; 71(10):2549-2563. PubMed ID: 35292828 [TBL] [Abstract][Full Text] [Related]
2. A subset of patients with MSS/MSI-low-colorectal cancer showed increased CD8(+) TILs together with up-regulated IFN-γ. Kikuchi T; Mimura K; Okayama H; Nakayama Y; Saito K; Yamada L; Endo E; Sakamoto W; Fujita S; Endo H; Saito M; Momma T; Saze Z; Ohki S; Kono K Oncol Lett; 2019 Dec; 18(6):5977-5985. PubMed ID: 31788072 [TBL] [Abstract][Full Text] [Related]
3. Presence of Tim3 Klapholz M; Drage MG; Srivastava A; Anderson AC J Pathol; 2022 Jun; 257(2):186-197. PubMed ID: 35119692 [TBL] [Abstract][Full Text] [Related]
4. Cytolytic activity correlates with the mutational burden and deregulated expression of immune checkpoints in colorectal cancer. Zaravinos A; Roufas C; Nagara M; de Lucas Moreno B; Oblovatskaya M; Efstathiades C; Dimopoulos C; Ayiomamitis GD J Exp Clin Cancer Res; 2019 Aug; 38(1):364. PubMed ID: 31429779 [TBL] [Abstract][Full Text] [Related]
5. The Potential Value of Immunotherapy in Colorectal Cancers: Review of the Evidence for Programmed Death-1 Inhibitor Therapy. Toh JWT; de Souza P; Lim SH; Singh P; Chua W; Ng W; Spring KJ Clin Colorectal Cancer; 2016 Dec; 15(4):285-291. PubMed ID: 27553906 [TBL] [Abstract][Full Text] [Related]
6. Blocking IL-17A enhances tumor response to anti-PD-1 immunotherapy in microsatellite stable colorectal cancer. Liu C; Liu R; Wang B; Lian J; Yao Y; Sun H; Zhang C; Fang L; Guan X; Shi J; Han S; Zhan F; Luo S; Yao Y; Zheng T; Zhang Y J Immunother Cancer; 2021 Jan; 9(1):. PubMed ID: 33462141 [TBL] [Abstract][Full Text] [Related]
7. High density of cytotoxic T-lymphocytes is linked to tumoral PD-L1 expression regardless of the mismatch repair status in colorectal cancer. Möller K; Blessin NC; Höflmayer D; Büscheck F; Luebke AM; Kluth M; Hube-Magg C; Zalewski K; Hinsch A; Neipp M; Mofid H; Lárusson H; Daniels T; Isbert C; Coerper S; Ditterich D; Rupprecht H; Goetz A; Bernreuther C; Sauter G; Uhlig R; Wilczak W; Simon R; Steurer S; Minner S; Burandt E; Krech T; Perez D; Izbicki JR; Clauditz TS; Marx AH Acta Oncol; 2021 Sep; 60(9):1210-1217. PubMed ID: 34092167 [TBL] [Abstract][Full Text] [Related]
8. Increased CD8 Tumor Infiltrating Lymphocytes in Colorectal Cancer Microenvironment Supports an Adaptive Immune Resistance Mechanism of PD-L1 Expression. Sudoyo AW; Kurniawan AN; Kusumo GD; Putra TP; Rexana FA; Yunus M; Budiyati AD; Kurniawan D; Utama A; Utomo AR Asian Pac J Cancer Prev; 2019 Nov; 20(11):3421-3427. PubMed ID: 31759368 [TBL] [Abstract][Full Text] [Related]
9. Prognostic implication of CD274 (PD-L1) protein expression in tumor-infiltrating immune cells for microsatellite unstable and stable colorectal cancer. Lee KS; Kwak Y; Ahn S; Shin E; Oh HK; Kim DW; Kang SB; Choe G; Kim WH; Lee HS Cancer Immunol Immunother; 2017 Jul; 66(7):927-939. PubMed ID: 28405764 [TBL] [Abstract][Full Text] [Related]
10. Targeting CD96 overcomes PD-1 blockade resistance by enhancing CD8+ TIL function in cervical cancer. Wang Y; Wang C; Qiu J; Qu X; Peng J; Lu C; Zhang M; Zhang M; Qi X; Li G; Hua K J Immunother Cancer; 2022 Mar; 10(3):. PubMed ID: 35288463 [TBL] [Abstract][Full Text] [Related]
11. The Balance Between Cytotoxic T-cell Lymphocytes and Immune Checkpoint Expression in the Prognosis of Colon Tumors. Marisa L; Svrcek M; Collura A; Becht E; Cervera P; Wanherdrick K; Buhard O; Goloudina A; Jonchère V; Selves J; Milano G; Guenot D; Cohen R; Colas C; Laurent-Puig P; Olschwang S; Lefèvre JH; Parc Y; Boige V; Lepage C; André T; Fléjou JF; Dérangère V; Ghiringhelli F; de Reynies A; Duval A J Natl Cancer Inst; 2018 Jan; 110(1):. PubMed ID: 28922790 [TBL] [Abstract][Full Text] [Related]
12. TIGIT and PD1 Co-blockade Restores ex vivo Functions of Human Tumor-Infiltrating CD8 Ge Z; Zhou G; Campos Carrascosa L; Gausvik E; Boor PPC; Noordam L; Doukas M; Polak WG; Terkivatan T; Pan Q; Takkenberg RB; Verheij J; Erdmann JI; IJzermans JNM; Peppelenbosch MP; Kraan J; Kwekkeboom J; Sprengers D Cell Mol Gastroenterol Hepatol; 2021; 12(2):443-464. PubMed ID: 33781741 [TBL] [Abstract][Full Text] [Related]
13. Co-expression of PD-1 with TIGIT or PD-1 with TIM-3 on tumor-infiltrating CD8 Meyiah A; Mahmoodi Chalbatani G; Al-Mterin MA; Malekraeisi MA; Murshed K; Elkord E Int Immunopharmacol; 2023 Jun; 119():110207. PubMed ID: 37099940 [TBL] [Abstract][Full Text] [Related]
14. T-cell immunoglobulin and ITIM domain, as a potential immune checkpoint target for immunotherapy of colorectal cancer. Fathi M; Pustokhina I; Kuznetsov SV; Khayrullin M; Hojjat-Farsangi M; Karpisheh V; Jalili A; Jadidi-Niaragh F IUBMB Life; 2021 May; 73(5):726-738. PubMed ID: 33686787 [TBL] [Abstract][Full Text] [Related]
15. Dysfunctional tumor-infiltrating Vδ1 + T lymphocytes in microsatellite-stable colorectal cancer. Stary V; Pandey RV; List J; Kleissl L; Deckert F; Kabiljo J; Laengle J; Gerakopoulos V; Oehler R; Watzke L; Farlik M; Lukowski SW; Vogt AB; Stary G; Stockinger H; Bergmann M; Pilat N Nat Commun; 2024 Aug; 15(1):6949. PubMed ID: 39138181 [TBL] [Abstract][Full Text] [Related]
16. Clinical significance of programmed cell death-ligand 1 expression and the immune microenvironment at the invasive front of colorectal cancers with high microsatellite instability. Korehisa S; Oki E; Iimori M; Nakaji Y; Shimokawa M; Saeki H; Okano S; Oda Y; Maehara Y Int J Cancer; 2018 Feb; 142(4):822-832. PubMed ID: 29044503 [TBL] [Abstract][Full Text] [Related]
17. Tiragolumab plus atezolizumab versus placebo plus atezolizumab as a first-line treatment for PD-L1-selected non-small-cell lung cancer (CITYSCAPE): primary and follow-up analyses of a randomised, double-blind, phase 2 study. Cho BC; Abreu DR; Hussein M; Cobo M; Patel AJ; Secen N; Lee KH; Massuti B; Hiret S; Yang JCH; Barlesi F; Lee DH; Ares LP; Hsieh RW; Patil NS; Twomey P; Yang X; Meng R; Johnson ML Lancet Oncol; 2022 Jun; 23(6):781-792. PubMed ID: 35576957 [TBL] [Abstract][Full Text] [Related]
18. CD8 Millen R; Hendry S; Narasimhan V; Abbott R; Croxford M; Gibbs P; Tie J; Wong HL; Jones I; Kosmider S; Byrne D; Zalcberg J; Fox S; Desai J; Visvanathan K; Ramsay RG; Tran B Clin Transl Immunology; 2020; 9(7):e1155. PubMed ID: 32953115 [TBL] [Abstract][Full Text] [Related]
19. Chang Wei Qing Decoction enhances the anti-tumor effect of PD-1 inhibitor therapy by regulating the immune microenvironment and gut microbiota in colorectal cancer. Wang T; Wu L; Wang S; Shi X; Liu H; Deng W Chin J Nat Med; 2023 May; 21(5):333-345. PubMed ID: 37245872 [TBL] [Abstract][Full Text] [Related]
20. Subtyping of microsatellite stability colorectal cancer reveals guanylate binding protein 2 (GBP2) as a potential immunotherapeutic target. Wang H; Zhou Y; Zhang Y; Fang S; Zhang M; Li H; Xu F; Liu L; Liu J; Zhao Q; Wang F J Immunother Cancer; 2022 Apr; 10(4):. PubMed ID: 35383115 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]